Item request has been placed!
×
Item request cannot be made.
×
Processing Request
Detection and characterization of IgE-binding factors (IgE-BF) within supernatants of the cell line RPMI-8866, normal human sera and sera from atopic patients.
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
- معلومة اضافية
- المصدر:
Publisher: Blackwell Scientific Publications Country of Publication: England NLM ID: 0374672 Publication Model: Print Cited Medium: Print ISSN: 0019-2805 (Print) Linking ISSN: 00192805 NLM ISO Abbreviation: Immunology Subsets: MEDLINE
- بيانات النشر:
Original Publication: Oxford : Blackwell Scientific Publications
- الموضوع:
- نبذة مختصرة :
IgE-binding factors (IgE-BF) have been shown to be important regulatory factors for IgE induction and suppression. The analysis of IgE-binding factor activity by a modified inhibition radioimmunoassay (RIA), as well as by monoclonal antibodies (mAb) was carried out in the supernatant of the Fc epsilon RII+ cell line RPMI-8866 as well as in human sera. Kinetics of IgE-BF showed optimal release from RPMI-8866 cells after 3-4 days. Gel filtration of the supernatant indicated binding activity at less than 100,000, 45,000 and 25,000 MW. Within normal human sera two peaks of IgE-BF activity were obtained at 45,000 and 25,000 MW. In sera with high IgE levels (atopic dermatitis) a peak at less than 100,000 was MW detected. Within this peak endogenous IgE was present. Addition of sodium dodecylsulphate induced a release of IgE-BF with a MW of 60,000.
- References:
Eur J Immunol. 1986 Mar;16(3):306-12. (PMID: 2937643)
Arzneimittelforschung. 1985;35(12A):1953-7. (PMID: 2937412)
Eur J Immunol. 1986 Sep;16(9):1043-7. (PMID: 3019705)
J Exp Med. 1986 Nov 1;164(5):1455-69. (PMID: 2945890)
Immunology. 1986 Dec;59(4):569-75. (PMID: 2433216)
Proc Natl Acad Sci U S A. 1987 Feb;84(3):819-23. (PMID: 2949326)
Eur J Immunol. 1986 Dec;16(12):1627-30. (PMID: 3028819)
Immunology. 1987 Apr;60(4):539-45. (PMID: 3495483)
Eur J Immunol. 1987 Jun;17(6):757-61. (PMID: 2954825)
EMBO J. 1987 Jun;6(6):1637-42. (PMID: 3038527)
J Clin Invest. 1977 Apr;59(4):616-24. (PMID: 321474)
J Immunol. 1981 May;126(5):1692-6. (PMID: 6971311)
J Immunol. 1981 Jun;126(6):2087-92. (PMID: 7229368)
J Immunol. 1982 Jan;128(1):289-95. (PMID: 6459370)
J Immunol Methods. 1983 Mar 11;58(1-2):59-71. (PMID: 6601161)
J Immunol. 1983 Dec;131(6):2751-6. (PMID: 6227664)
J Immunol. 1983 Dec;131(6):2772-6. (PMID: 6227666)
Proc Natl Acad Sci U S A. 1984 Mar;81(5):1514-8. (PMID: 6231643)
J Allergy Clin Immunol. 1984 Aug;74(2):109-20. (PMID: 6205033)
Immunology. 1984 Sep;53(1):1-8. (PMID: 6469280)
Eur J Immunol. 1984 Oct;14(10):871-8. (PMID: 6237918)
Immunology. 1984 Oct;53(2):207-14. (PMID: 6092268)
Immunology. 1984 Dec;53(4):783-90. (PMID: 6238905)
J Exp Med. 1985 Jul 1;162(1):45-59. (PMID: 2989413)
Immunology. 1985 Jul;55(3):481-8. (PMID: 3160655)
Methods Enzymol. 1985;116:76-94. (PMID: 4088090)
J Clin Invest. 1986 Mar;77(3):952-7. (PMID: 3485112)
Eur J Immunol. 1986 Jul;16(7):809-14. (PMID: 2941308)
- الرقم المعرف:
0 (Lymphokines)
0 (Prostatic Secretory Proteins)
0 (beta-microseminoprotein)
0 (immunoglobulin-binding factors)
- الموضوع:
Date Created: 19880901 Date Completed: 19881222 Latest Revision: 20181113
- الموضوع:
20221213
- الرقم المعرف:
PMC1385019
- الرقم المعرف:
3181994
No Comments.